FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to 4-heteriocyclylsolfoneamidyl-6-methoxy-5-(2-methoxyphenoxy)-2-pyridylpyrimidine derivatives of the formula (I) where R1 means heterocyclic fragment taken among pyridyl and thiazolyl where this heterocyclic fragment is substituted optionally with (lower) alkyl or (lower) alkenyl and to their pharmaceutically acceptable salts. These compounds are inhibitors of endothelin receptors and therefore they can be used for treatment of patients with diseases associated with anomalous vascular tonus and endothelial dysfunction. EFFECT: valuable medicinal properties of compounds. 9 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
4-(HETEROCYCLYLSULFONAMIDO)-5-METHOXY-6-(2-METHOXYPHENOXY)-2-PHENYL- OR PYRIDYLPYRIMIDINES AS ENDOTHELIN RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2224757C2 |
SULFONAMIDES AND PHARMACEUTICAL PREPARATION | 1995 |
|
RU2162084C2 |
SULFONAMIDES AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2151767C1 |
DERIVATIVES OF ARYL- AND HETEROARYLSULFONEAMIDES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1995 |
|
RU2163598C2 |
SULFONEAMIDE DERIVATIVES AND PHARMACEUTICAL PREPARATION | 1996 |
|
RU2173317C2 |
DERIVATIVES OF DIHYDROBENZODIAZEPIN-2-ONE FOR TREATMENT OF NEUROLOGICAL DISORDERS | 2003 |
|
RU2315764C2 |
SULFAMIDES AND THEIR USING | 1997 |
|
RU2192257C2 |
DERIVATIVES OF PYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2284997C2 |
MODULATORS OF ADENOSINE RECEPTORS | 2001 |
|
RU2277911C2 |
BENZENESULFONAMIDE DERIVATIVES OF PYRIMIDINE OR THEIR SALTS, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASES ASSOCIATED WITH ENDOTHELIN ACTIVITY | 1992 |
|
RU2086544C1 |
Authors
Dates
2003-04-10—Published
2000-02-28—Filed